Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is -5.15% vs 1,876.27% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -8.37% vs 36.57% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -28.98% vs 53.41% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is -10.69% vs 41.28% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of BridgeBio Pharma, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -5.15% vs 1,876.27% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 4,927.27% vs 37.50% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -8.37% vs 36.57% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -143.44% vs 53.02% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -28.98% vs 53.41% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 22.74% vs -21.43% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -10.69% vs 41.28% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 64.19% vs 11.17% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






